OtherCardiovascular
Inhibition of G6PD activity attenuates right ventricle pressure and hypertrophy elicited by VEGFR inhibitor + hypoxia
Atsushi Kitagawa, Christina Jacob, Allan Jordan, Ian Waddell, Ivan F Mcmurtry and Sachin A Gupte
Journal of Pharmacology and Experimental Therapeutics March 23, 2021, JPET-AR-2020-000166; DOI: https://doi.org/10.1124/jpet.120.000166
Atsushi Kitagawa
1Pharmacology, New York Medical College, United States
Christina Jacob
1Pharmacology, New York Medical College, United States
Allan Jordan
2Drug Discovery Unit, Cancer Research UK Manchester Institute, United Kingdom
Ian Waddell
2Drug Discovery Unit, Cancer Research UK Manchester Institute, United Kingdom
Ivan F Mcmurtry
3Pharmacology and Medicine, University of South Alabama, United States
Sachin A Gupte
1Pharmacology, New York Medical College, United States
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherCardiovascular
G6PD, DNA methylation, and PAH
Atsushi Kitagawa, Christina Jacob, Allan Jordan, Ian Waddell, Ivan F Mcmurtry and Sachin A Gupte
Journal of Pharmacology and Experimental Therapeutics March 23, 2021, JPET-AR-2020-000166; DOI: https://doi.org/10.1124/jpet.120.000166
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement